Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jiwon Oh

Showing results (21-30 of 291) with videos related to

Pageof 30
Sort By:
The Lancet. Neurology|October 5, 2013
Emerging injectable therapies for multiple sclerosisJiwon Oh, Peter A Calabresi
Nature Reviews. Neurology|January 14, 2015
Multiple sclerosis in 2014. Progress in MS--classification, mechanisms and treatmentJiwon Oh, Paul W O'Connor
Therapeutic Advances in Neurological Disorders|October 25, 2014
Teriflunomide in the treatment of multiple sclerosis: current evidence and future prospectsJiwon Oh, Paul W O'Connor
Current Opinion in Neurology|April 30, 2015
Established disease-modifying treatments in relapsing-remitting multiple sclerosisJiwon Oh, Paul W O'Connor
Current Opinion in Neurology|April 19, 2015
Novel and imminently emerging treatments in relapsing-remitting multiple sclerosisJiwon Oh, Paul W O'Connor
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 23, 2020
New imaging approaches for precision diagnosis and disease staging of MS?Jiwon Oh, Nancy L Sicotte
Seminars in Neurology|May 28, 2013
Teriflunomide for the treatment of multiple sclerosisJiwon Oh, Paul W O'Connor
The Lancet. Neurology|November 19, 2022
Ublituximab: a new anti-CD20 agent for multiple sclerosisJiwon Oh, Amit Bar-Or
Neurology. Clinical Practice|August 6, 2013
TeriflunomideJiwon Oh, Paul W O'Connor
Spinal Cord Series and Cases|September 5, 2017
Response to 'Foix-Alajouanine is another differential diagnosis in longitudinal myelitis thought to be a case of multiple sclerosis or neuromyelitis optica'Suradech Suthiphosuwan, Jiwon Oh, Aditya Bharatha
Pageof 30

Showing results (21-30 of 291) with videos related to

Sort By:
Pageof 30
The Lancet. Neurology|October 5, 2013
Emerging injectable therapies for multiple sclerosisJiwon Oh, Peter A Calabresi
Nature Reviews. Neurology|January 14, 2015
Multiple sclerosis in 2014. Progress in MS--classification, mechanisms and treatmentJiwon Oh, Paul W O'Connor
Therapeutic Advances in Neurological Disorders|October 25, 2014
Teriflunomide in the treatment of multiple sclerosis: current evidence and future prospectsJiwon Oh, Paul W O'Connor
Current Opinion in Neurology|April 30, 2015
Established disease-modifying treatments in relapsing-remitting multiple sclerosisJiwon Oh, Paul W O'Connor
Current Opinion in Neurology|April 19, 2015
Novel and imminently emerging treatments in relapsing-remitting multiple sclerosisJiwon Oh, Paul W O'Connor
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 23, 2020
New imaging approaches for precision diagnosis and disease staging of MS?Jiwon Oh, Nancy L Sicotte
Seminars in Neurology|May 28, 2013
Teriflunomide for the treatment of multiple sclerosisJiwon Oh, Paul W O'Connor
The Lancet. Neurology|November 19, 2022
Ublituximab: a new anti-CD20 agent for multiple sclerosisJiwon Oh, Amit Bar-Or
Neurology. Clinical Practice|August 6, 2013
TeriflunomideJiwon Oh, Paul W O'Connor
Spinal Cord Series and Cases|September 5, 2017
Response to 'Foix-Alajouanine is another differential diagnosis in longitudinal myelitis thought to be a case of multiple sclerosis or neuromyelitis optica'Suradech Suthiphosuwan, Jiwon Oh, Aditya Bharatha
Pageof 30